Keyphrases
Exosomes
100%
Allogeneic
100%
T Cells
83%
Transplantation
60%
Autoreactive T Cells
60%
Rheumatoid Arthritis
50%
Pharmacogenetics
50%
Antigenicity
50%
Passenger Leukocytes
50%
T Cell Response
50%
Immunogenicity
50%
Antigen-presenting Cells
46%
Major Histocompatibility Complex
33%
Major Histocompatibility Complex Molecules
33%
Recipient Cells
33%
Leukocytes
33%
Allograft Rejection
26%
Single nucleotide Polymorphism
25%
Lymphoid Organs
16%
Immunosuppressive Therapy
16%
Heart Transplantation
16%
Spleen
16%
Immune Therapy
16%
Islet Graft
16%
Nephrotoxicity
16%
Microvesicles
16%
Islet Transplantation
16%
Infection Risk
16%
Allogeneic Skin
16%
Neoplasia
16%
Imaging Flow Cytometry
16%
NO Donors
16%
Early Acute Rejection
16%
Lymphocytes
16%
Donor Cells
16%
Lymph Node
16%
End-organ Disease
16%
Alloimmune Response
16%
Allotransplantation
16%
Lifesaving
16%
Influence Factors
12%
Molecular Sequencing
12%
Remission
12%
Drug-metabolizing Enzymes
12%
Trial-and-error
12%
Inflammatory Arthritis
12%
Drug Efficacy
12%
Autoimmune
12%
Genetic Factors
12%
Treatment Advances
12%
Immunology and Microbiology
Exosome
100%
T Cell
87%
Alloreactive T Cell
60%
Antigenicity
50%
Major Histocompatibility Complex
50%
Passenger Leukocyte
50%
Immunogenicity
50%
Antigen-Presenting Cell
42%
Leukocyte
25%
Transplant Rejection
22%
Heart Transplantation
12%
Immunosuppressive Therapy
12%
Lymphocyte
12%
Lymph Node
12%
Lymphoid Organ
12%
Immunity
12%
Allograft
12%
Acute Graft Rejection
12%
Flow Imaging
12%
Islet Transplantation
12%
Alloantigen
10%
Medicine and Dentistry
Major Histocompatibility Complex
50%
Alloreactive T Cell
50%
T-Cell Response
50%
Leukocyte
50%
Exosome
50%
T Cell
25%
Acute Graft Rejection
12%
Allograft
12%
Flow Cytometry
12%
Terminal Illness
12%
Lymph Node
12%
Nephrotoxicity
12%
Immunity
12%
Islet Transplantation
12%
Lymphocyte
12%
Graft Rejection
12%
Infection
12%
Antigen Presenting Cell
12%
Immunosuppressive Treatment
12%
In Vitro
12%
Lymphoid Organ
12%
Leukocyte Transfusion
12%
Neoplasm
12%
